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Background: Chronic Obstructive Pulmonary Disease (COPD) is a major cause of morbidity and mortality at global level
even if still underestimated. The insufficient use of specific tools for an objective definition and staging, the inadequate
awareness of COPD, but also a difficult patient-to-doctor communication, can contribute to the poor management
of COPD. A very simple, short and sensitive questionnaire (the “COPD Assessment Test” - CAT questionnaire) is
now available for assessing the impact of COPD on the patient’s health. The present study was designed to provide
such evidence using data generated throughout Italy.
Methods: The Italian validated version of the CAT questionnaire was distributed to 681 consecutive COPD patients
of different severity (males = 480), well matched for age, gender, smoking habit, geographical distribution, BMI,
dyspnoea score and educational level. The CAT score variability was investigated vs all anagraphic, and clinical
variables, and spirometric indices of lung function (regression). No Italian data are available to our knowledge on
the CAT use, neither in General Medicine, nor in the specialist setting.
Results: Data of this study confirmed that the CAT questionnaire is a sensitive, simple, and quick tool for assessing
the respiratory status of COPD patients. The CAT score proved not conditioned by the patient’s age, gender, body
size, geographical origin, and educational level. It was inversely correlated with the spirometric values, even if not
uniquely linked to them.
Conclusions: The CAT score does not represent a surrogate measurement of lung function: it is an instrument
which focuses on different areas of respiratory health in COPD patients, thus providing an useful and objective
tool for the long-term clinical and therapeutic monitoring of COPD patients in the specialist outpatient setting.
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Chronic Obstructive Pulmonary Disease (COPD) is a major
cause of morbidity and mortality at global level [1,2], and in
Italy affects approximately 10% of adults over the age of 40.
The main aim of treatment for COPD is to reduce the
symptoms of the disease keeping the patient as healthy
as possible.
However, despite the combined efforts of the major
international scientific institutions (the American Thoracic* Correspondence: robertodalnegro@gmail.com
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article, unless otherwise stated.Society (ATS), the European Respiratory Society (ERS),
the GOLD Guidelines) in an attempt to find the most ap-
propriate diagnosis and treatment for COPD [3,4], this
disease is still often greatly underestimated both from a
diagnostic and from a therapeutic point of view [5-9].
This causes a further significant increase in the economic
and socio-economic impact of COPD, mainly due to direct
costs (over 70% even in Italy) relative to frequent health
emergencies, hospitalizations, and loss of productivity de-
riving from the clinically uncontrolled disease [5-8]. From a
general point of view, these findings indicate that COPD is
still widely underestimated from a therapeutic viewpoint,tral Ltd. This is an Open Access article distributed under the terms of the
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and emotional health.
There are several concomitant factors contributing to
such a poor management: the inadequate awareness of
COPD as an effective disease (particularly in its early
stages); the insufficient use of specific diagnostic tools
(even basic tests, such as spirometry) for a more objective
definition and staging; and the uneven availability of lung
services that our country still suffers from; the insufficient
prescription of appropriate and prolonged treatments even
for patients already diagnosed; shortage of time; the general
practitioner’s difficulty in timely identifying these patients,
and finally, the real patient’s difficulty to communicate his/
her medical condition to the doctor effectively, which is
often perceived (and thus referred) incorrectly [9].
One of the most critical aspects is the lack of simple, re-
producible, and specific tools, capable of raising awareness
among doctors and patients concerning the true value of
patient’s claimed severity of symptoms, as well as of his
objective limitations in respiratory health status and qua-
lity of life.
Current specific tools (questionnaires) for measuring
the quality of life are quite capable of representing the
criticality of COPD patients (i.e. The St. George's Respira-
tory Questionnaire – SGRQ), but they take so long time
to be filled in properly (even in their short form) that they
are not used at all in clinical practice.
Recently, a very simple, short and specific question-
naire was validated (such as the “CAT questionnaire” or
COPD Assessment Test) in order to assess precisely the
impact of COPD on the patient’s health. In its definitive
version, it consists of eight questions (each on a scale of
0 to 5, with an overall score range of 0–40) which cover
various domains of respiratory health status [10] (cough;
production of secretions; tightness in the chest; short-
ness of breath when walking upstairs; housework; ease
of living at home; quality of sleep; energy). This tool has
proved to be accurate and extremely simple, easy to
understand, as well as very easy and quick for the pa-
tient to fill in [10-13] (Figure 1).
As to our knowledge no Italian data are still available
on the CAT use, neither in the General Medicine nor in
the Pneumological context, the present study was de-
signed to investigate the variability and the consistency
of the CAT questionnaire in COPD outpatients referring
to lung structures throughout Italy.
Methods
The Italian validated version of the CAT questionnaire was
distributed to consecutive subjects suffering from COPD of
different clinical severity (GOLD Guidelines 2011). Each
subject was assessed spirometrically (complete spirometry
performed by means of CPFS/D – Medical Graphics Co.;
Oak Grove Parkway, St. Paul, Minnesota, USA), and thefollowing indices were collected: FEV1% predicted; Vital
Capacity (VC)% predicted; MMEF% predicted; FEV1/FVC%;
FEV1/VC%.
The Dyspnea score was calculated with the MRC sca-
leand BMI (Body Mass Index) was also calculated for
each subject.
Smoking habit was taken into account (expressed as
no. of packs per year), together with the subjects’ educa-
tional level; any comorbidity (in terms of type and num-
ber); the ongoing regular treatment (drugs in the R03
category of the NTP); the number of steroids and/or an-
tibiotics courses followed in the last 12 months (such as
a surrogate index of true acute exacerbations).
Statistics: the distribution of values for the patients’
age and their CAT score was checked; mean values ±
SD were compared by t unpaired test; all possible re-
lationships between the CAT scores and the values of
all other variables were checked by linear regression.
Due to the huge number of different comparisons,
p < 0.01 was accepted as the minimum level of statis-
tical significance.
Results
A total of 681 consecutive COPD patients of different
severity were enrolled, coming from different Italian re-
gions. They proved geographically well matched: from
the North n = 248, (36.4%); the Centre n = 209, (30.7%);
the South and the islands: n = 224, (32.9%).
The general characteristics of the population are sum-
marized in Table 1, also by gender.
Table 2 reports mean values of lung function measured
in the population, together with the corresponding mean
value of MRC and the CAT score: in general terms, sub-
jects characterized by a mild-to-moderate condition were
prevailing, even though a 20% of subjects were severe
(Figure 2). Males appeared slightly more compromised
than females, but no significant difference was seen by
gender between the corresponding CAT scores (t test =
ns). The mean CAT score for the Italian sample was also
shown to be extremely close to those for the other Euro-
pean countries [11,12].
Figures 2 and 3 report the distribution of the FEV1 and
CAT values respectively in the population as a whole (the
corresponding mean values ± SD are those shown in
Table 2). In the case of FEV1, it is easy to realize how the
distribution of values was very close to a normal distribu-
tion, with an extremely low skewness score. The mean
CAT score corresponds perfectly to that observed in other
European countries [10]. The distribution of CAT values
was centered in the range 5 and 25. When distribution of
CAT values was limited to subjects with a FEV1 < 80% pre-
dicted (n = 398), the asymmetry of the distribution shape
remains almost unchanged, despite a slight increase in the
mean CAT score (17.3 ± 7.0 sd) (Figure 4).
Figure 1 The CAT questionnaire in its validated Italian version.
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values of all the other variables led to the following results:
– No significant correlation was assessed between the
CAT score and gender, age, BMI, and the
educational level of subjects, respectively:
 vs gender: (Y = 16.2 + .26 X) p = 0.67
 vs age: (Y = 13.6 + 4.1 X) p = 0.15 vs BMI: (Y = 13.7 + 9.8X) p = 0.07
 Vs educational level: (Y = 16.9 – 0.1X) p = 0.65
– The smoking habit proved not significant per se,
even if a positive correlation was found for the no.
pack/years, being the correlation index rather low
(r = 0.08):
 vs smoking: (Y = 17.6-0.4X) p = 0.25
 vs pack/years: (Y = 15.9 + 2.1 X) p = 0.03
Table 1 General characteristics of the population
(n = 681)
Population Men Women
n. 681 480 201
Age (mean, years) 72.3 ± 9.6 sd 72.9 ± 9.1 sd 70.8 ± 10.4 sd
Origin (%)
North 36.4% 71.8% 28.2%
Center 30.7% 73.4% 26.8%
South + Islands 32.9% 75.9% 24.1%
Smoking
smokers (%) 14.5% 13.1% 17.9%
no. of pack/years 29.3 ± 27.6 sd 35.4 ± 28.0 sd 15.1 ± 20.3 sd
ex-smokers (%) 63.9% 75.7% 35.8%
non-smokers (%) 21.6% 11.2% 46.3%
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spirometric indices considered, even if the
correlation indices were singularly very low:
 vs FEV1% (Y = 21.0 -.06X) p < 0.001 r = −0.21
 vs VC% (Y = 23.2-7.5 X) p < 0.001 r = −0.20
 vs MMEF% (Y = 17.1-3.3X) p = 0.008 r = −0.10
 vs FEV1/FVC% (Y = 21.3-7.6X) p < 0.001 r = −0.14
 vs FEV1/VC% (Y = 20.4-6.4X) p = 0.001 r = −0.13
– A strong and significant positive correlation was
seen with the dyspnea score:
 vs MRC score (Y = 11.4 + 4.2 X) p < 0.001 r = 0.62
A confirmation for these findings comes from
the CAT score, which was significantly and
positively related to the extent of dyspnea at rest
(p < 0.001;
r = 0.27) and during exercise (p < 0.001; r = 0.37),
and of wheezing (p < 0.006; r = 0.11).
– A significant positive correlation was also found
with the no. of courses of systemic steroids and of
antibiotics (both expression of the occurrence ofble 2 Lung function and MRC score (n = 681)
Population Men Women t test
V1 (% pred) 72.6 ± 24.1 sd 69.7 ± 23.3 sd 79.4 ± 24.7 sd
C (% pred) 88.7 ± 19.4 sd 85.2 ± 18.4 sd 97.0 ± 19.0 sd
(% pred) 88.6 ± 18.7 sd 86.4 ± 18.3 sd 94.1 ± 18.5 sd
MEF (% pred) 33.9 ± 21.8 sd 33.9 ± 21.7 sd 33.7 ± 22.0 sd
V1/FVC (%) 62.7 ± 13.2 sd 61.3 ± 13.1 sd 66.1 ± 12.9 sd
V1/VC (%) 60.7 ± 14.5 sd 58.9 ± 14.4 sd 65.0 ± 13.8 sd
RC (score) 1.2 ± 1.0 sd 1.2 ± 1.1 sd 1.3 ± 1.0 sd
T (score) 16.6 ± 7.1 16.5 ± 7.1 sd 16.8 ± 7.2 sd nsacute exacerbations) in the previous 12 months,
though singularly with a low correlation index:
 vs no. of steroid cycles (Y = 16.0 + 2.6 X)
p < 0.001 r = 0.19
 vs no. of antibiotic cycles (Y = 15.9 + 1.7 X)
p < 0.001 r = 0.16
– The infectious respiratory comorbidities (bronchial
exacerbations and/or pneumonia) showed a mild
positive correlation with the CAT score, even
though the correlation index was quite low:
 vs no. infectious respiratory comorbidities
(Y = 16.1 + 1.5 X) p = 0.02 r = 0.10
Only comorbidities of metabolic and neurological
cause (but not the cardiovascular,
gastroenterological, metabolic, neurological,
neoplasticones) showed some correlation with the
CAT score, though with very low correlation indices:
 vs no. metabolic comorbidities (Y = 16.0 + 2.0 X)
p = 0.001 r = 0.12
 vs no. neurological comorbidities (Y = 16.4 + 2.6 X)
p = 0.02 r = 0.09
A slight correlation was also found between the
CAT score and the no. of comorbidities
documented:
 vs no. of comorbidities (Y = 14.2 + 0.7 X)
p < 0.001 r = 0.21
It is interesting to note that, when the variation of the
CAT score was checked vs the current therapeutic treat-
ment, the CAT scores proved significantly higher in the
untreated patients, as well as in those treated only with
short-acting β2-adrenergics on demand (p > 0.002), and
in those only assuming oral xanthines (p < 0.047). No
significant correlation was found in subjects undergoing
regular treatment with long-term appropriate strategies,
such as long-acting bronchodilators and/or inhaled cor-
ticosteroids (all p = ns).
Finally, even though the link was rather weak (r =
0.08), the variations in the CAT score proved signifi-
cantly related (p < 0.030) to the no. of respiratory drugs
(belonging to the R03category in the NTP) used by the
patients, and thus with the complexity of their ongoing
treatment.
Discussion
Data from the present study, which was carried out in a
representative sample of italian COPD outpatients refer-
ring to a lung Unit, confirm the sensitivity and the
consistency of the CAT questionnaire, and lead to suggest
and support its use as a quick and specific clinical tool for
assessing the respiratory health status of COPD patients.
The CAT questionnaire also proved to be very sensitive in
capturing the intra-patient variations in health status dur-
ing COPD, and it provides significant variations in the
Figure 2 Distribution of FEV1% predicted values (by 10% intervals) for the total sample (n = 681).
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and acute clinical exacerbation phases of the disease. It is
a coincidence that the correlation with the specific COPD
version of the St. George’s Respiratory Questionnaire was
particularly high (r = 0.80) [10-12].
It should be underlined that the CAT score proved not
affected by the age, gender, body size, and the educa-
tional level of COPD patient’s, thus further emphasizing
its stability in assessing the patients’ health status.Figure 3 Distribution of CAT scores (by 5 point intervals) for the totaFurthermore, even if the CAT score obviously proves
significantly inversely correlated to the values of lung
functions, it is not strictly and uniquely linked to them:
in other words, it does not represent, therefore, an al-
ternative measurement to lung function but, on the
contrary, it focuses on different areas of the respiratory
health in COPD patients, thus providing an useful, ob-
jective, and instantaneous tool for the long-term clin-
ical and therapeutic monitoring of COPD patients inl sample (n = 681).
Figure 4 Distribution of CAT scores (by 5 point intervals) in patients with FEV1 < 80% predicted.
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the stronger link between the CAT score and the re-
spiratory symptoms (such as dyspnoea and wheezing)
reported by the patient.
Unlike previous international investigations, the present
study proved a significant relationship between the CAT
score and the occurrence of respiratory infections. To-
gether with the significant positive relationship assessed
between the CAT score and the frequency of steroid and/
or antibiotic courses in the previous year, this feature em-
phasizes and explains the ability of the CAT questionnaire
to highlight the variations in health status due to the oc-
currence of acute COPD exacerbations.
Finally, the evidence indicating that the CAT score
proved to be significantly higher in patients currently
untreated, or improperly managed, further suggests that
the CAT is a sensitive tool for assessing the COPD pa-
tient’s “current” respiratory status.
Conclusions
The CAT questionnaire is thus confirmed as a simple
and reliable tool which is capable of measuring COPD-
related health status. Thanks to its unique characteris-
tics, it thus seems particularly useful in the specialist
outpatient settings, particularly for long-term clinical
and therapeutic monitoring of COPD patients.
Finally, the availability of a reproducible and consistent
tool which is able to ensure the quick, easy, and effective
patient-to-doctor communication, can only lead to a
substantial improvement in the health-related and socio-
economic impact of COPD by providing a more appro-
priate therapeutic management and a more effective
governance of COPD.
On the basis of findings from European studies [10-13]
(and now also from Italian data), internal consistency testsfor the questionnaire confirm that the CAT is a suitable
and reliable instrument for measuring patient-assessed
COPD-related health status regardless of language diffe-
rences. This is of particular significance because it ensures
the validity and relevance of the CAT as an international
cross-cultural assessment tool for comparing the impact
of COPD.
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